Crystal structures of agonist-bound human cannabinoid receptor CB1.

The cannabinoid receptor 1 (CB₁) is the principal target of the psychoactive constituent of marijuana, the partial agonist Δ⁹-tetrahydrocannabinol (Δ⁹-THC). Here we report two agonist-bound crystal structures of human CB₁ in complex with a tetrahydrocannabinol (AM11542) and a hexahydrocannabinol (AM841) at 2.80 Å and 2.95 Å resolution, respectively. The two CB₁-agonist complexes reveal important conformational changes in the overall structure, relative to the antagonist-bound state, including a 53% reduction in the volume of the ligand-binding pocket and an increase in the surface area of the G-protein-binding region. In addition, a ‘twin toggle switch’ of Phe200^3.36 and Trp356^6.48 (superscripts denote Ballesteros-Weinstein numbering) is experimentally observed and appears to be essential for receptor activation. The structures reveal important insights into the activation mechanism of CB₁ and provide a molecular basis for predicting the binding modes of Δ⁹-THC, and endogenous and synthetic cannabinoids. The plasticity of the binding pocket of CB₁ seems to be a common feature among certain class A G-protein-coupled receptors. These findings should inspire the design of chemically diverse ligands with distinct pharmacological properties.